Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.
Wilson E, Goswami J, Baqui AH, Doreski PA, Perez-Marc G, Zaman K, Monroy J, Duncan CJA, Ujiie M, Rämet M, Pérez-Breva L, Falsey AR, Walsh EE, Dhar R, Wilson L, Du J, Ghaswalla P, Kapoor A, Lan L, Mehta S, Mithani R, Panozzo CA, Simorellis AK, Kuter BJ, Schödel F, Huang W, Reuter C, Slobod K, Stoszek SK, Shaw CA, Miller JM, Das R, Chen GL; ConquerRSV Study Group. Wilson E, et al. Among authors: ujiie m. N Engl J Med. 2023 Dec 14;389(24):2233-2244. doi: 10.1056/NEJMoa2307079. N Engl J Med. 2023. PMID: 38091530 Clinical Trial.
Monkeypox.
Moriyama Y, Ujiie M. Moriyama Y, et al. Among authors: ujiie m. N Engl J Med. 2023 Feb 16;388(7):671. doi: 10.1056/NEJMc2215751. N Engl J Med. 2023. PMID: 36791179 No abstract available.
Global Outbreak Alert and Response Network (GOARN) focal point engagement meeting with partners in Japan.
Iwasaki H, Salmon S, Matsuzawa Y, Lee S, Takagi K, Nomoto H, Ishikane M, Ujiie M, Ohmagari N. Iwasaki H, et al. Among authors: ujiie m. Western Pac Surveill Response J. 2024 Jan 30;15(5 Spec edition):1-3. doi: 10.5365/wpsar.2024.15.5.1100. eCollection 2024. Western Pac Surveill Response J. 2024. PMID: 38523828 Free PMC article. No abstract available.
Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults.
Morino E, Mine S, Tomita N, Uemura Y, Shimizu Y, Saito S, Suzuki T, Okumura N, Iwasaki H, Terada J, Ainai A, Sakai Y, Park E, Seki S, Akazawa D, Shimojima M, Shiwa-Sudo N, Virhuez-Mendoza M, Miyauchi K, Moriyama S, Iwata-Yoshikawa N, Harada M, Harada S, Hishiki T, Kotaki R, Matsumura T, Miyamoto S, Kanno T, Isogawa M, Watashi K, Nagata N, Ebihara H, Takahashi Y, Maeda K, Matano T, Wakita T, Suzuki T, Sugiura W, Ohmagari N, Ujiie M. Morino E, et al. Among authors: ujiie m. NEJM Evid. 2024 Mar;3(3):EVIDoa2300290. doi: 10.1056/EVIDoa2300290. Epub 2024 Feb 27. NEJM Evid. 2024. PMID: 38411447
An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox.
Tomita N, Terada-Hirashima J, Uemura Y, Shimizu Y, Iwasaki H, Yano R, Suzuki T, Saito S, Okumura N, Sugiura W, Ohmagari N, Ujiie M. Tomita N, et al. Among authors: ujiie m. Hum Vaccin Immunother. 2023 Aug 1;19(2):2242219. doi: 10.1080/21645515.2023.2242219. Hum Vaccin Immunother. 2023. PMID: 37559375 Free PMC article. Clinical Trial.
"Take" after LC16m8 for mpox.
Okumura N, Ishikane M, Ujiie M, Ohmagari N. Okumura N, et al. Among authors: ujiie m. Int J Infect Dis. 2023 Sep;134:290-291. doi: 10.1016/j.ijid.2023.07.005. Epub 2023 Jul 13. Int J Infect Dis. 2023. PMID: 37451393 Free article. No abstract available.
115 results